Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cancers|February 27, 2020
The c-Myc/AKT1/TBX3 Axis Is Important to Target in the Treatment of Embryonal RhabdomyosarcomaDanica Sims, Hapiloe Mabaruti Maranyane, Victoria Damerell, et al.
Journal of Cellular and Molecular Medicine|July 28, 2025
The T-Box Transcription Factors TBX2 and TBX3 Are Molecular Targets of Piroctone Olamine in the Treatment of Pancreatic CancerKarabo Serala, Sanele Mdletshe, Jinming Bai, et al.
Tumour Virus Research|April 23, 2022
Cervical cancer therapies: Current challenges and future perspectivesCarly A Burmeister, Saif F Khan, Georgia Schäfer, et al.
Cancer Letters|December 24, 2017
Disulfiram with or without metformin inhibits oesophageal squamous cell carcinoma in vivoRupal Jivan, Jade Peres, Leonard Howard Damelin, et al.
Frontiers in Oncology|February 11, 2022
The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating CellsVictoria Damerell, Melvin Anyasi Ambele, Shanel Salisbury, et al.
European Journal of Medicinal Chemistry|January 14, 2024
Aminoquinoline-based Re(I) tricarbonyl complexes: Insights into their antiproliferative activity and mechanisms of actionPaige S Zinman, Athi Welsh, Reinner O Omondi, et al.
Molecular Cancer Research : MCR|September 12, 2024
c-Myc, AKT, Hsc70, and the T-Box Transcription Factor TBX3 Form an Important Oncogenic Signaling Axis in Breast CancerStephanie M Ncube, ArulJothi Nagarajan, Dirk Lang, et al.
Experimental Cell Research|May 12, 2023
Intracellular mechanics and TBX3 expression jointly dictate the spreading mode of melanoma cells in 3D environmentsGhodeejah Higgins, Faatiemah Higgins, Jade Peres, et al.
The Journal of Investigative Dermatology|March 21, 2021
TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITFJade Peres, Victoria Damerell, Jagat Chauhan, et al.
Pageof 9